Polo; John M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Polo; John M..The latest application filed is for "method for the purification of alphavirus replicon particles".

Company Profile

1.23.18

Polo; John M. - Rancho Santa Fe CA
Polo; John M - Hayward CA US
Polo; John M. - Hayward CA
Polo; John M - San Diego CA
Polo; John M. - Encinitas CA
Polo; John M. - San Diego CA
Polo; John M. - Danville CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chimeric alphavirus replicon particles Grant 9,255,126 - Polo , et al. February 9, 2	2016-02-09
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems Grant 8,647,864 - Polo , et al. February 11, 2	2014-02-11
Method for the Purification of Alphavirus Replicon Particles App 20120231526 - Polo; John M. ; et al.	2012-09-13
Eukaryotic layered vector initiation systems Grant 7,977,091 - Dubensky, Jr. , et al. July 12, 2	2011-07-12
Recombinant Alphavirus-based Vectors With Reduced Inhibition Of Cellular Macro-molecular Synthesis App 20100330121 - Dubensky, JR.; Thomas W. ; et al.	2010-12-30
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 7,811,812 - Dubensky, Jr. , et al. October 12, 2	2010-10-12
Eukaryotic Layered Vector Initiation Systems App 20100173412 - Dubensky, JR.; Thomas W. ; et al.	2010-07-08
Enhancement of the immune response for vaccine and gene therapy applications Grant 7,744,900 - Dubensky, Jr. , et al. June 29, 2	2010-06-29
Method For The Purification Of Alphavirus Replicon Particles App 20100055128 - Polo; John M. ; et al.	2010-03-04
Chimeric Alphavirus Replicon Particles App 20090304745 - Polo; John M. ; et al.	2009-12-10
Chimeric Alphavirus Replicon Particles App 20090305344 - POLO; John M. ; et al.	2009-12-10
Eukaryotic layered vector initiation systems Grant 7,572,628 - Dubensky, Jr. , et al. August 11, 2	2009-08-11
Chimeric alphavirus replicon particles Grant 7,572,453 - Polo , et al. August 11, 2	2009-08-11
Chimeric alphavirus replicon particles Grant 7,531,180 - Polo , et al. May 12, 2	2009-05-12
Enhancement Of The Immune Response For Vaccine And Gene Therapy Applications App 20080292655 - Dubensky, JR.; Thomas W. ; et al.	2008-11-27
Chimeric alphavirus replicon particles App 20060292175 - Polo; John M. ; et al.	2006-12-28
Severe acute respiratory syndrome coronavirus App 20060257852 - Rappuoli; Rino ; et al.	2006-11-16
Method for the purification of alphavirus replicon particles App 20050112752 - Polo, John M. ; et al.	2005-05-26
Method for the quantitation of alphavirus replicon particles Grant 6,767,699 - Polo , et al. July 27, 2	2004-07-27
Eukaryotic layered vector initiation systems App 20040029278 - Dubensky, Thomas W. JR. ; et al.	2004-02-12
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis App 20030232058 - Dubensky, Thomas W. JR. ; et al.	2003-12-18
Chimeric alphavirus replicon particles App 20030232324 - Polo, John M. ; et al.	2003-12-18
Eukaryotic layered vector initiation systems App 20030232035 - Dubensky, Thomas W. JR. ; et al.	2003-12-18
Alphavirus-based vectors for persistent infection App 20030170871 - Dubensky, Thomas W. JR. ; et al.	2003-09-11
Chimeric alphavirus replicon particles App 20030148262 - Polo, John M. ; et al.	2003-08-07
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis App 20030096397 - Schlesinger, Sondra ; et al.	2003-05-22
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,465,634 - Dubensky, Jr. , et al. October 15, 2	2002-10-15
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,458,560 - Dubensky, Jr. , et al. October 1, 2	2002-10-01
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,451,592 - Dubensky, Jr. , et al. September 17, 2	2002-09-17
Alphavirus structural protein expression cassettes Grant 6,426,196 - Dubensky, Jr. , et al. July 30, 2	2002-07-30
Recombinant alphavirus particles Grant 6,376,236 - Dubensky, Jr. , et al. April 23, 2	2002-04-23
Method for the purification of alphavirus replicon particles App 20020015945 - Polo, John M. ; et al.	2002-02-07
Eukaryotic layered vector initiation systems for production of recombinant proteins Grant 6,342,372 - Dubensky, Jr. , et al. January 29, 2	2002-01-29
Compositions and methods for packaging of alphavirus vectors Grant 6,329,201 - Polo , et al. December 11, 2	2001-12-11
Method for stimulating an immune response utilizing recombinant alphavirus particles Grant 6,015,694 - Dubensky, Jr. , et al. January 18, 2	2000-01-18
Eukaryotic layered vector initiation systems Grant 6,015,686 - Dubensky, Jr. , et al. January 18, 2	2000-01-18
Alphavirus vector constructs Grant 5,843,723 - Dubensky, Jr. , et al. December 1, 1	1998-12-01
Eukaryotic layered vector initiation systems Grant 5,814,482 - Dubensky, Jr. , et al. September 29, 1	1998-09-29
Alphavirus structural protein expression cassettes Grant 5,789,245 - Dubensky, Jr. , et al. August 4, 1	1998-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.